Klarsen reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was EUR 0.871 million compared to EUR 0.834 million a year ago. Net income was EUR 0.163 million compared to EUR 0.157 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.19 EUR | -3.52% | -22.48% | -19.49% |
Mar. 15 | Acticor Biotech Raises EUR8 Million to Fund Emergency Stroke Treatment Development | MT |
2023 | Acticor Biotech’s Phase 2/3 Trial for Stroke Drug Combo on Track for 2024 Results | MT |
1st Jan change | Capi. | |
---|---|---|
-19.49% | 7.82M | |
-13.45% | 191B | |
+1.32% | 167B | |
+1.32% | 152B | |
+3.83% | 99.13B | |
+7.97% | 78.79B | |
+21.50% | 75.03B | |
-8.21% | 70.51B | |
-19.94% | 53.21B | |
-8.05% | 43.78B |
- Stock Market
- Equities
- ALKLA Stock
- News Klarsen
- Klarsen Reports Earnings Results for the Half Year Ended June 30, 2022